Inhibition of the p50 (NFκB1) Subunit of NF-κB by Phosphorothioate-Modified Antisense Oligodeoxynucleotides Reduces NF-κB Expression and Immunoglobulin Synthesis in Murine B Cells
- 30 June 1997
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 83 (3) , 254-263
- https://doi.org/10.1006/clin.1997.4354
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysisImmunity, 1995
- Advances in antisense efficacy and deliveryTrends in Biotechnology, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agentsCellular and Molecular Neurobiology, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Timing of immunosuppression in the natural history of autoimmune diseaseJournal of Autoimmunity, 1992
- Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expressionClinical and Experimental Immunology, 1992
- Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?Pharmacology & Therapeutics, 1991
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986